DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

H.C. Wainwright Reiterates Buy on Stemline Therapeutics, Lowers Price Target to $20

H.C. Wainwright reiterates Stemline Therapeutics (NASDAQ:STML) with a Buy and lowers the price target from $35 to $20.

Benzinga · 01/21/2020 12:58

H.C. Wainwright reiterates Stemline Therapeutics (NASDAQ:STML) with a Buy and lowers the price target from $35 to $20.